| 10.62 Data as of Mar 14 |  -0.03 / -0.28%Today’s Change | 3.85 Today|||52-Week Range 11.48 | +31.93% Year-to-Date |
| Previous close | 10.65 |
| Today’s open | 10.75 |
| Day’s range | 10.35 - 10.77 |
| Volume | 167,970 |
| Average volume (3 months) | 107,760 |
| Market cap | $270.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +63.96% |
| Earnings growth (this year) | -1,230.77% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | -20.13% |
| P/E ratio | NM |
| Price/Sales | 2.92 |
| Price/Book | 8.85 |
| Today’s change | Today’s % change | |
|---|---|---|
| ADHDAlcobra Ltd | -0.01 | -0.05% |
| ATHXAthersys Inc | -0.13 | -3.53% |
| NAVBNavidea Biopharmaceu... | +0.02 | +1.00% |
| POZNPOZEN Inc | +0.02 | +0.23% |
| Next reporting date | May 12, 2014 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $26.1M |
| Annual profit (last year) | -$3.2M |
| Net profit margin | -12.37% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Investor Relations Contact Stephen H. Willard |
Chief Executive Officer & Director Michael Shannon Anderson |
Corporate headquarters Vénissieux, Rhone-alpes |
.
